Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Free Cash Flow (2017 - 2025)

Historic Free Cash Flow for Q32 Bio (QTTB) over the last 9 years, with Q3 2025 value amounting to -$4.5 million.

  • Q32 Bio's Free Cash Flow rose 7738.81% to -$4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$39.8 million, marking a year-over-year increase of 4123.51%. This contributed to the annual value of -$68.6 million for FY2024, which is 25902.93% down from last year.
  • As of Q3 2025, Q32 Bio's Free Cash Flow stood at -$4.5 million, which was up 7738.81% from -$10.9 million recorded in Q2 2025.
  • Q32 Bio's 5-year Free Cash Flow high stood at $15.8 million for Q3 2023, and its period low was -$31.8 million during Q1 2022.
  • For the 5-year period, Q32 Bio's Free Cash Flow averaged around -$18.0 million, with its median value being -$19.8 million (2024).
  • In the last 5 years, Q32 Bio's Free Cash Flow surged by 16331.7% in 2023 and then crashed by 22530.72% in 2024.
  • Quarter analysis of 5 years shows Q32 Bio's Free Cash Flow stood at -$30.8 million in 2021, then grew by 11.57% to -$27.2 million in 2022, then skyrocketed by 60.2% to -$10.8 million in 2023, then dropped by 7.87% to -$11.7 million in 2024, then skyrocketed by 61.7% to -$4.5 million in 2025.
  • Its Free Cash Flow stands at -$4.5 million for Q3 2025, versus -$10.9 million for Q2 2025 and -$12.7 million for Q1 2025.